G. Lagrue, A. Branellec, and P. Niaudet, Transmission of nephrotic syndrome to two neonates. Spontaneous regression, Presse Med, vol.20, pp.255-262, 1991.

L. Gallon, J. Leventhal, and A. Skaro, Resolution of recurrent focal segmental glomerulosclerosis after retransplantation, N Engl J Med, vol.366, pp.1648-1657, 2012.

R. J. Shalhoub, Pathogenesis of lipoid nephrosis: a disorder of T-cell function, Lancet, vol.2, pp.556-60, 1974.

C. A. Janeway, The management of nephrosis, Pediatrics, vol.2, p.705, 1948.

G. Lagrue, S. Xheneumont, and A. Branellec, A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome, Biomedicine, vol.23, pp.37-40, 1975.

K. Benz, J. Dotsch, W. Rascher, and D. Stachel, Change of the course of steroiddependent nephrotic syndrome after rituximab therapy, Pediatr Nephrol, vol.19, pp.794-801, 2004.

T. H. Yoo, C. E. Pedigo, and J. Guzman, Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease, J Am Soc Nephrol, vol.26, pp.133-180, 2015.

M. Ollero and D. Sahali, Inhibition of the VEGF signalling pathway and glomerular disorders, Nephrol Dial Transplant, vol.30, pp.1449-55, 2015.

M. Delville, T. K. Sigdel, and C. Wei, A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation, Sci Transl Med, vol.6, pp.256-136, 2014.

E. H. Garin, W. Mu, and J. M. Arthur, Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis, Kidney Int, vol.78, pp.296-302, 2010.

C. C. Yu, A. Fornoni, and A. Weins, Abatacept in B7-1-positive proteinuric kidney disease, N Engl J Med, vol.369, pp.2416-2439, 2013.

K. W. Lai, C. L. Wei, and L. K. Tan, Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats, J Am Soc Nephrol, vol.18, pp.1476-85, 2007.

E. T. Mccarthy, M. Sharma, and V. J. Savin, Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis, Clin J Am Soc Nephrol, vol.5, pp.2115-2136, 2010.

D. Raveh, O. Shemesh, and Y. J. Ashkenazi, Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome, Pediatr Nephrol, vol.19, pp.1281-1285, 2004.

W. W. Bakker, J. F. Baller, and W. H. Van-luijk, A kallikrein-like molecule and plasma vasoactivity in minimal change disease, Contrib Nephrol, vol.67, pp.31-37, 1988.

C. Wei, C. C. Moller, and M. M. Altintas, Modification of kidney barrier function by the urokinase receptor, Nat Med, vol.14, pp.55-63, 2008.

E. Kemeny, M. J. Mihatsch, U. Durmuller, and F. Gudat, Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis, Clin Nephrol, vol.43, pp.71-83, 1995.

L. C. Clement, C. Avila-casado, and C. Mace, Podocyte-secreted angiopoietinlike-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome, Nat Med, vol.17, pp.117-139, 2011.

S. Sever, H. Trachtman, C. Wei, and J. Reiser, Is there clinical value in measuring suPAR levels in FSGS?, Clin J Am Soc Nephrol, vol.8, pp.1273-1278, 2013.

M. M. Schwartz, J. Evans, R. Bain, and S. M. Korbet, Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion, J Am Soc Nephrol, vol.10, pp.1900-1907, 1999.

K. N. Campbell and J. A. Tumlin, Protecting podocytes: a key target for therapy of focal segmental glomerulosclerosis, Am J Nephrol, vol.47, issue.1, pp.14-29, 2018.

R. Sharma, M. Sharma, and E. T. Mccarthy, Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro, Kidney Int, vol.58, pp.1973-1982, 2000.

Y. Harita, K. Ishizuka, and A. Tanego, Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis, Pediatr Nephrol, vol.29, pp.1553-60, 2014.

C. Faul, M. Donnelly, and S. Merscher-gomez, The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A, Nat Med, vol.14, pp.931-939, 2008.

S. Beaudreuil, X. Zhang, and H. Florence, Circulating CASK is associated with recurrent focal segmental glomerulosclerosis after transplantation, PLoS One, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02264103

J. Müller-deile, H. Schenk, and P. Schroder, Circulating factors cause proteinuria in parabiotic zebrafish, Kidney Int, issue.19, pp.30232-30239, 2019.

. Liens-d'inte?re?t,

, Les auteurs déclarent n'avoir aucun lien d'intérêt concernant les données publiées dans cet article

V. G. Puelles, W. E. Hoy, and M. D. Hughson, Glomerular number and size variability and risk for kidney disease, Curr Opin Nephrol Hypertens, vol.20, pp.7-15, 2011.

O. Cil and F. Perwad, Monogenic causes of proteinuria in children, Front Med, vol.5, p.55, 2018.

E. D. O'sullivan, J. Hughes, and D. A. Ferenbach, Renal aging: causes and consequences, J Am Soc Nephrol, vol.28, pp.407-427, 2017.

V. D. D'agati, F. J. Kaskel, and R. J. Falk, Focal segmental glomerulosclerosis, N Engl J Med, vol.365, pp.2398-411, 2011.

V. Audard, P. Lang, and D. Sahali, Pathogénie du syndrome néphrotique à lesions glomérulaires minimes, Med Sci (Paris), vol.24, pp.853-861, 2008.

S. Y. Zhang, V. Audard, P. Lang, and D. Sahali, Mécanismes moléculaires du syndrome néphrotique idiopathique à rechutes: rôle de c-mip dans les dysfonctions podocytaires, Med Sci, vol.26, pp.592-598, 2010.

T. H. Banh, N. Hussain-shamsy, and V. Patel, Ethnic differences in incidence and outcomes of childhood nephrotic syndrome, Clin J Am Soc Nephrol, vol.11, pp.1760-1768, 2016.

A. Meyrier and P. Niaudet, Acute kidney injury complicating nephrotic syndrome of minimal change disease, Kidney Int, vol.94, pp.861-870, 2018.

S. Uezono, S. Hara, and Y. Sato, Renal biopsy in elderly patients: a clinicopathological analysis, Renal Failure, vol.28, pp.549-55, 2006.

A. C. Mendonca, E. A. Oliveira, and B. P. Froes, A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome, Pediatr Nephrol, vol.30, pp.2011-2031, 2015.

M. H. Han and Y. J. Kim, Practical application of Columbia classification for focal segmental glomerulosclerosis, BioMed Res Int, p.9375753, 2016.

B. L. Wharram, M. Goyal, and J. E. Wiggins, Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene, J Am Soc Nephrol, vol.16, pp.2941-52, 2005.

B. Smeets, C. Kuppe, and E. M. Sicking, Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis, J Am Soc Nephrol, vol.22, pp.1262-74, 2011.

M. M. O'shaughnessy, S. L. Hogan, and C. J. Poulton, Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, Clin J Am Soc Nephrol, vol.12, pp.614-637, 1986.

V. J. Savin, M. Sharma, and J. Zhou, Multiple targets for novel therapy of FSGS associated with circulating permeability factor, BioMed Res Int, p.6232616, 2017.

J. H. Ehrich, C. Geerlings, and M. Zivicnjak, Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated, Nephrol Dial Transplant, vol.22, pp.2183-93, 2007.

M. Sharma, J. Zhou, and J. F. Gauchat, Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier, Transl Res, vol.166, pp.384-98, 2015.

A. B. Fogo, Causes and pathogenesis of focal segmental glomerulosclerosis, Nat Rev Nephrol, vol.11, pp.76-87, 2015.

A. Tejani, K. Phadke, and A. Nicastri, Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions, Nephron, vol.41, pp.170-173, 1985.

R. J. Maas, J. K. Deegens, and B. Smeets, Minimal change disease and idiopathic FSGS: manifestations of the same disease, Nat Rev Nephrol, vol.12, pp.768-76, 2016.

A. Gentili, W. Tangheroni, and G. Gelli, Proteinuria caused by transfusion of blood from nephrotic to nonnephrotic individuals, Minerva Medica, vol.45, pp.603-611, 1954.

J. R. Hoyer, R. L. Vernier, and J. S. Najarian, Recurrence of idiopathic nephrotic syndrome after renal transplantation, Lancet, vol.2, pp.343-351, 1972.

A. R. Rich, A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis, Bull Johns Hopkins Hosp, vol.100, pp.173-86, 1957.

J. R. Hoyer, R. L. Vernier, and J. S. Najarian, Recurrence of idiopathic nephrotic syndrome after renal transplantation, J Am Soc Nephrol, vol.12, pp.1994-2002, 1972.

J. Dantal, A. Testa, E. Bigot, and J. P. Soulillou, Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation, Ann Med Interne, vol.143, issue.1, pp.48-51, 1992.

M. L. Artero, R. Sharma, V. J. Savin, and F. Vincenti, Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis, Am J Kidney Dis, vol.23, pp.574-81, 1994.

J. Dantal, Y. Godfrin, and R. Koll, Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome, J Am Soc Nephrol, vol.9, pp.1709-1724, 1998.

S. W. Zimmerman, Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation, Clin Nephrol, vol.22, pp.32-40, 1984.

V. J. Savin, R. Sharma, and M. Sharma, Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis, N Engl J Med, vol.334, pp.878-83, 1996.